Literature DB >> 32862395

Effect of Lactobacillus delbrueckii Subsp. lactis PTCC1057 on Serum Glucose, Fetuin-A ,and Sestrin 3 Levels in Streptozotocin-Induced Diabetic Mice.

Jamal Hallajzadeh1, Reza Dolatyari Eslami2, Asghar Tanomand3.   

Abstract

Intake of probiotic bacteria may improve or preserve insulin sensitivity. Fetuin-A and sestrin 3 have emerged as promising candidate biomarkers for crucial roles in insulin signaling pathway. Therefore, the effect of oral supplementation with the probiotic bacterium Lactobacillus delbrueckii subsp. lactis PTCC1057 on proteins involved in insulin signaling pathway was investigated in normal and streptozotocin (STZ)-induced diabetic mice. The 6-8-week-old female mice were divided into a non-diabetic control, diabetic control, and diabetic experimental and non-diabetic experimental groups (5 mice each group). Diabetic and non-diabetic experimental groups treated with 3 × 107 CFU mL-1 L. delbrueckii subsp. lactis PTCC1057 by gavage feeding approach daily for 28 days. Serum glucose, fetuin-A, and sestrin 3 levels were measured by standard methods. The result showed that oral administration of L. delbrueckii significantly decreased serum glucose in comparison to diabetic control group (P = 0.01). Serum fetuin-A level was higher in diabetic control group than non-diabetic group and oral administration of L. delbrueckii subsp. lactis PTCC1057 significantly decreased fetuin-A level in diabetic experimental group in comparison with non-diabetic groups (P = 0.001). Sestrin 3 level significantly was lower in diabetic control group than non-diabetic control group (P = 0.03) and it significantly increased in diabetic experimental group in comparison with diabetic control group after intervention of L. delbrueckii subsp. lactis PTCC1057 (P = 0.02). The results show that feeding the STZ-induced diabetic mice with L. delbrueckii subsp. lactis PTCC1057 terminated to decrease in fasting blood glucose and fetuin-A level and increase in serum sestrin 3 level. Therefore, the L. delbrueckii subsp. lactis PTCC1057 can be considered as excellent candidate for future studies on diabetes mellitus.

Entities:  

Keywords:  Fetuin-A; Lactobacillus delbrueckii subsp. lactis PTCC1057; STZ; Sestrin 3; Streptozotocin; Type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 32862395     DOI: 10.1007/s12602-020-09693-0

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  43 in total

1.  Garlic in alloxan-induced diabetic rabbits.

Authors:  R C Jain; C R Vyas
Journal:  Am J Clin Nutr       Date:  1975-07       Impact factor: 7.045

2.  Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects.

Authors:  Katsuhito Mori; Masanori Emoto; Hisayo Yokoyama; Takahiro Araki; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Diabetes Care       Date:  2006-02       Impact factor: 19.112

3.  [What should an administration official in a leading position know about rehabilitation?].

Authors:  E Schirmer
Journal:  Z Gesamte Hyg       Date:  1972-01

4.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

Review 5.  Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes.

Authors:  C R Kahn
Journal:  Diabetes       Date:  1994-08       Impact factor: 9.461

6.  Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults.

Authors:  Nadja Larsen; Finn K Vogensen; Frans W J van den Berg; Dennis Sandris Nielsen; Anne Sofie Andreasen; Bente K Pedersen; Waleed Abu Al-Soud; Søren J Sørensen; Lars H Hansen; Mogens Jakobsen
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

7.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

8.  Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities.

Authors:  Y Fukino; A Ikeda; K Maruyama; N Aoki; T Okubo; H Iso
Journal:  Eur J Clin Nutr       Date:  2007-06-06       Impact factor: 4.016

9.  Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling.

Authors:  Rongya Tao; Xiwen Xiong; Suthat Liangpunsakul; X Charlie Dong
Journal:  Diabetes       Date:  2014-11-05       Impact factor: 9.461

Review 10.  Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?

Authors:  Aastha Chawla; Rajeev Chawla; Shalini Jaggi
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug
View more
  3 in total

1.  Safety Evaluation of Lactobacillus delbrueckii subsp. lactis CIDCA 133: a Health-Promoting Bacteria.

Authors:  Luís Cláudio Lima de Jesus; Thiago de Jesus Sousa; Flávia Figueira Aburjaile; Vasco Azevedo; Nina Dias Coelho-Rocha; Rodrigo Profeta; Fernanda Alvarenga Lima Barroso; Mariana Martins Drumond; Pamela Mancha-Agresti; Ênio Ferreira; Bertram Brenig
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-17       Impact factor: 5.265

2.  Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum.

Authors:  Na Young Lee; Hyun Chae Joung; Byoung Kook Kim; Byung Yong Kim; Tae Sik Park; Ki Tae Suk
Journal:  Gut Microbes       Date:  2020-11-09

Review 3.  Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.

Authors:  Lixiang Zhai; Jiayan Wu; Yan Y Lam; Hiu Yee Kwan; Zhao-Xiang Bian; Hoi Leong Xavier Wong
Journal:  Int J Mol Sci       Date:  2021-11-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.